New drug combination tested against aggressive cervical cancer
NCT ID NCT00421096
Summary
This study tested whether adding a follow-up chemotherapy drug (gemcitabine) after standard radiation and chemotherapy could better control advanced cervical cancer. It involved 19 women with stage IB2 to IVA cervical cancer who had not received prior cancer treatments. The trial was terminated early, so full results are not available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Leonard de Vinci
Dechy, 59187, France
-
Centre Oscar Lambret
Lille, 59020, France
Conditions
Explore the condition pages connected to this study.